![Cynthia Pussinen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Cynthia Pussinen served as the Chief Executive Officer & Director at Sernova Corp.
from 2023 to 2024.
Prior to that, she was the Chief Technical Officer at Spark Therapeutics, Inc. from 2021 to 2022.
She also held the position of Executive Vice President-Technical Development at Actinium Pharmaceuticals, Inc. Ms. Pussinen holds a graduate degree from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Connecticut.
Antiguos cargos conocidos de Cynthia Pussinen.
| Empresas | Cargo | Fin |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Director Ejecutivo | 12/08/2024 |
| SPARK THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/12/2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Cynthia Pussinen.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
2
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
- Bolsa de valores
- Insiders
- Cynthia Pussinen
